Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2006
Business Overview: The Company operates outpatient physical and occupational therapy clinics providing preventive, curative, and post-operative care. As of June 30, 2006, it operated 303 clinics in 39 states. The Company primarily operates through subsidiary clinic partnerships where it holds a majority interest, with managing therapists holding minority interests.
Key Financial Metrics
| Metric (in thousands, except per share) | Three Months Ended June 30, 2006 | Six Months Ended June 30, 2006 |
|---|---|---|
| Net Revenues | $35,758 | $70,414 |
| Operating Income | $4,612 | $8,162 |
| Net Income | $2,156 | $3,640 |
| Diluted EPS | $0.18 | $0.30 |
| Cash and Cash Equivalents | $13,564 | $13,564 (Balance Sheet) |
| Net Cash Provided by Operating Activities | N/A | $8,697 |
| Total Debt (Current + Long-term Notes) | $591 | $591 |
| Current Ratio | 5.4 to 1.0 | 5.4 to 1.0 |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 6.5% in the second quarter and 9.2% for the six months ended June 30, 2006, compared to the prior year periods. This was driven by an 8.8% increase in total patient visits (to 713,420 for the six months) and a slight increase in net patient revenue per visit.
- Profitability Decline: Despite revenue growth, Net Income decreased 21.9% for the quarter and 24.0% for the six months compared to the prior year. Operating income declined due to rising costs.
- Cost Pressures: Salaries and related costs increased 13.0% for the quarter and 14.9% for the six months, rising as a percentage of net revenues to 52.3% and 52.8% respectively. This is attributed to high demand and limited supply of licensed physical therapists.
- Accounting Change: The adoption of SFAS 123R (Share-Based Payment) on January 1, 2006, resulted in a non-cash stock-based compensation expense of $464,000 for the six months, reducing net income by $0.02 per share.
- Clinic Activity: The Company added 20 new clinics and closed 3 clinics during the first six months of 2006.
Guidance, Outlook, and Risks
- Liquidity: Management believes cash equivalents and marketable securities ($15.1 million total) are sufficient to fund operations and development through at least June 2007. The Company has an unsecured $5 million credit facility with no outstanding balance.
- Capital Allocation: The Company repurchased 131,218 shares of common stock for $2.1 million during the six months. Approximately 324,000 shares remain available for repurchase under existing programs.
- Medicare Cap Risk: The Medicare therapy cap was reinstated effective January 1, 2006, at $1,740. While an exception process exists, the cap could result in lost revenues if not mitigated by marketing to non-Medicare sources or staffing adjustments.
- Forward-Looking Statements: The Company expects initial operating losses from new clinics opened in 2006. Risks include reimbursement rate changes, regulatory compliance, and competitive conditions.
Investor Verification Checklist
- Medicare Cap Impact: Verify the extent of revenue loss or mitigation strategies regarding the reinstated $1,740 Medicare therapy cap.
- Salary Inflation: Monitor the trend of "Salaries and related costs" as a percentage of revenue, which has risen significantly due to therapist shortages.
- Stock-Based Compensation: Review the impact of SFAS 123R adoption on future earnings, noting $2.7 million in future pre-tax expense for nonvested options.
- Clinic Performance: Assess the contribution of "New Clinics" versus "Mature Clinics" to revenue growth, noting that mature clinics saw a slight decline in visits in the quarter.
- Debt Obligations: Confirm repayment schedules for acquisition-related notes (Hamilton and Excel acquisitions) totaling approximately $591,000.